Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Benefits Seen in High-Risk Patients The strongest benefits were observed in individuals already considered at high cardiovascular risk, including people with obesity, type 2 diabetes, or existing heart disease
[DOI] [PubMed] [Google Scholar] Monks TJ, Ghersi-Egea JF, Philbert M, Cooper AJ, Lock EA
This may be especially true for people with diabetes, who are already at higher risk of yeast infections due to higher blood sugar levels and a compromised immune system
Clinical trials have demonstrated substantial efficacy for tirzepatide in both glycemic control and weight reduction
US$ 29.30
US$ 24.43
US$ 20.74
US$ 23.98
US$ 25.07
US$ 20.89
US$ 27.97
